News
First quarterContinuing operations1· Net sales increased 2.7 per cent to MSEK 694 (676), of which organic growth was 2.7 per cent· Adjusted EBITA amounted to MSEK 20 (19), with an adjusted ...
May 2025 is a month of transition, introspection, and rising career momentum for Leo natives. The Suns transit from the Ninth ...
Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics ...
DALLAS, April 16, 2025 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) has released its first quarter 2025 financial results. The 1Q 2025 financial results and shareholder letter are ...
Good morning, and thanks for joining us for Fulton Financial's conference call and webcast to discuss our earnings for the first quarter ending March 31, 2025. Your host for today's conference call is ...
Michael S. Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated, "We were pleased to share three presentations yesterday which we believe demonstrate our continued commitment to ...
The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Select companies are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results